Zacks Investment Research on MSN
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
Last week, QuidelOrtho Corporation QDEL announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the ...
So when and how should you use them? By Dani Blum Yet again this winter, millions of Americans will wonder if a nagging cough or body aches is a sign they’re coming down with Covid or the flu. This ...
Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback